it has a short elimination half-life and , as parkinson 's disease progresses , the brain loses its capacity to store the drug and becomes dependent in a moment-to-moment fashion on plasma levodopa concentrations , creating therapeutic response fluctuations in over 50 % of patients .
C0030567
parkinson 's disease
C0023570
levodopa